Indications
Therapeutic Asset Ratings
6,302 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Adoptive Therapy With Autologous Mc2 Tcr T Cells
Uveal Melanoma
Erasmus Medical Center
P1/2
CC
(46)
Allogenic Embryonic Stem Cell-Derived A9 Dopamine Progenitor Cell
Parkinson Disease
S.Biomedics Co., Ltd.
P1/2
CC
(46)
Amdx-2011P
Amyotrophic Lateral Sclerosis
Amydis Inc.
P1/2
CC
(46)
anv419
Metastatic Melanoma
Anaveon AG
P1/2
CC
(46)
Apg 115
Cancer
Ascentage Pharma Group Inc.
P1/2
CC
(46)
Apg 115
Melanoma
Ascentage Pharma Group Inc.
P1/2
CC
(46)
ARG
Lymphoma
ITM Solucin GmbH
P1/2
CC
(46)
Aro-Mmp7 Inhalation
Idiopathic Pulmonary Fibrosis
Arrowhead Pharmaceuticals
P1/2
CC
(46)
Atezolizumab
Pheochromocytoma
Cancer Research UK
P1/2
CC
(46)
Atezolizumab
Rhabdoid Tumor
National Cancer Institute (NCI)
P1/2
CC
(46)
Atezolizumab
Thyroid Cancer
TransThera Sciences (Nanjing), Inc.
P1/2
CC
(46)
Atezolizumab
Urinary Bladder Neoplasm
Cancer Research UK
P1/2
CC
(46)
Autologous Bcma/Cd19 Dual-Target Car-T Module
T-Cell Acute Lymphoblastic Leukemia
Beijing Biotech
P1/2
CC
(46)
Avutometinib
Colorectal Adenocarcinoma
University of Chicago
P1/2
CC
(46)
Azacitidine
Chronic Eosinophilic Leukemia
M.D. Anderson Cancer Center
P1/2
CC
(46)
Azacitidine
Myeloproliferative Neoplasm, Unclassifiable
M.D. Anderson Cancer Center
P1/2
CC
(46)
Azacitidine
Cellular Phase Chronic Idiopathic Myelofibrosis
M.D. Anderson Cancer Center
P1/2
CC
(46)
azd3470
Peripheral T-Cell Lymphoma, Not Otherwise Specified
AstraZeneca
P1/2
CC
(46)
Azenosertib
Acute Myeloid Leukemia
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
P1/2
CC
(46)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)-
Oral Cavity Cancer
VM Oncology, LLC
P1/2
CC
(46)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)-
Salivary Gland Carcinoma
VM Oncology, LLC
P1/2
CC
(46)
Bgb-16673
Follicular Lymphoma
BeiGene
P1/2
CC
(46)
Brigatinib
Inflammatory Myofibroblastic Tumor
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(46)
Briquilimab
Fanconi Anemia
Porteus, Matthew, MD
P1/2
CC
(46)
Bxq-350
Peripheral Neuropathy
Bexion Pharmaceuticals, Inc.
P1/2
CC
(46)
Showing 3151 to 3175 of 6,302 assets
Previous
Page 127 of 253
Next